Top 50 Companies in Lung Cancer Surgery Market 2025: Strategic Overview and Future Trends (2024–2035)
RELEASE DATE: Aug 2025 Author: Spherical InsightsRequest Free Sample Speak to Analyst
Description
According to a research report published by Spherical Insights & Consulting, The Global Lung Cancer Surgery Market Size is projected to Grow from USD 6.22 Billion in 2024 to USD 11.52 Billion by 2035, at a CAGR of 5.76% during the forecast period 2025–2035. The market for lung cancer surgeries is in greater demand because of the increased prevalence of lung cancer worldwide, which is driven by ageing populations, smoking, and pollution. Results and recuperation times are being improved by advances in surgical techniques, such as robotic-assisted surgeries and minimally invasive treatments. The market for lung cancer surgery is expanding due to a combination of factors such as increased awareness, early diagnosis through better screening programs, and easier access to healthcare.
Introduction
A medical treatment called lung cancer surgery is used to remove malignant tissue from the lungs. Depending on the patient's general health and the kind, location, and stage of the lung cancer, surgery may be the best course of treatment. Particularly in situations of early-stage non-small cell lung cancer and carcinoid tumours, it works best when the cancer is identified early and localised. To stop cancer from spreading, the tumour, surrounding lung tissue, and adjacent lymph nodes are surgically removed. Smoking, secondhand smoke, and exposure to carcinogens are the main causes of lung cancer. Surgery options include thoracotomy and minimally invasive procedures, which are selected according to the surgeon's experience and the features of the tumour. Lobectomy, segmentectomy, wedge resection, and pneumonectomy are common surgeries. Each may cause pain or other problems as a side effect. Minimally invasive technology advancements have improved the safety, accuracy, and painlessness of treatments. Increased early diagnosis and growing patient desire for efficient surgical treatment options are driving market expansion.
Navigate Future Markets with Confidence: Insights from Spherical Insights LLP
The insights presented in this blog are derived from comprehensive market research conducted by Spherical Insights LLP, a trusted advisory partner to leading global enterprises. Backed by in-depth data analysis, expert forecasting, and industry-specific intelligence, our reports empower decision-makers to identify strategic growth opportunities in fast-evolving sectors. Clients seeking detailed market segmentation, competitive landscapes, regional outlooks, and future investment trends will find immense value in the full report. By leveraging our research, businesses can make informed decisions, gain a competitive edge, and stay ahead in the transition toward sustainable and profitable solutions.
Unlock exclusive market insights-Download the Brochure now and dive deeper into the future of the Lung Cancer Surgery Market.
Lung Cancer Surgery Market Size & Statistics
- The Market Size for Lung Cancer Surgery Was Estimated to be worth USD 6.22 Billion in 2024.
- The Market is Going to Expand at a CAGR of 5.76% between 2025 and 2035.
- The Global Lung Cancer Surgery Market Size is anticipated to reach USD 11.52 Billion by 2035.
- North America is expected to generate the highest demand during the forecast period in the Lung Cancer Surgery Market
- Asia-Pacific is expected to grow the fastest during the forecast period in the Lung Cancer Surgery Market.
Regional growth and demand
Asia-Pacific is expected to grow the fastest during the forecast period in the lung cancer Surgery market. The market for lung cancer surgeries is now growing in Asia-Pacific due to improved healthcare infrastructure, growing knowledge of early diagnosis and treatment, and an increase in lung cancer incidences are the main drivers of this trend. Advanced surgical technologies are being adopted by nations such as China, India, and Japan. The area also enjoys the advantages of a sizable patient base, an ageing population, and increased healthcare spending, all of which support the Asia-Pacific lung cancer surgery market's explosive growth.
North America is expected to generate the highest demand during the forecast period in the Lung Cancer Surgery market. The lung cancer surgery market with the quickest rate of growth throughout the study period is anticipated to be in North America, because of its high prevalence of lung cancer and sophisticated healthcare system. Early detection, efficient treatment choices, and advantageous reimbursement systems are prioritised in the region. Both the United States and Canada have embraced cutting-edge surgical methods, particularly minimally invasive ones that minimise recovery time and problems, such as robotic-assisted surgeries and video-assisted thoracoscopic surgery. In addition to bolstering market expansion, ongoing research into personalised medicines improves patient outcomes and strengthens North America's dominant position in the market.
Top 10 trends in the Lung Cancer Surgery Market
- Rise of Minimally Invasive Surgeries
- Advancements in Robotic Surgery
- Early Diagnosis Through Screening Programs
- Growth in Personalized and Targeted Therapies
- Enhanced Imaging and Navigation Technologies
- Development of Lung-Preserving Techniques
- Rising Adoption of AI and Data Analytics
- Increased Focus on Postoperative Care and Rehabilitation
- Expanding Role of Multidisciplinary Teams
- Growing Global Access to Advanced Surgical Technologies
1. Rise of Minimally Invasive Surgeries
The landscape of lung cancer surgery is changing dramatically due to the increase in minimally invasive operations. Because of its advantages, procedures like robotic-assisted thoracic surgery and video-assisted thoracoscopic surgery are becoming more and more popular than open surgeries. Smaller incisions are used during these procedures, which lessens discomfort and leads to shorter hospital stays, quicker recovery periods, and fewer complications. Additionally, greater postoperative quality of life and superior cosmetic results are made possible by MIS. Surgeons can now execute intricate lung operations with more accuracy because of developments in surgical equipment and imaging technologies. A move towards patient-centric, effective, and outcome-focused surgical care in the treatment of lung cancer is reflected in the growing use of MIS.
2. Advancements in Robotic Surgery
Treatment for lung cancer is changing as a result of advancements in robotic surgery, which provide increased control, flexibility, and precision during operations. Robotic arms and high-definition 3D visualisation are used in robotic-assisted thoracic surgery (RATS), which allows surgeons to execute intricate procedures through tiny incisions. Unlike traditional or even other minimally invasive treatments, these systems improve dexterity and enable delicate movements. Less trauma, less discomfort, quicker healing, and less complications are among the advantages for patients. Additionally, robotic surgery makes it easier to access difficult-to-reach parts of the lung, which makes it perfect for some tumour placements. In contemporary thoracic surgery, this technique is becoming an essential.
3. Early Diagnosis Through Screening Programs
Lung cancer treatment outcomes are improving due to a major trend: early diagnosis through screening programs. A common screening technique for high-risk individuals, such as those who have smoked for a long time or have a family history of lung cancer, is low-dose computed tomography. By identifying tumours at an earlier stage, early detection increases the likelihood that surgical intervention will be successful. These initiatives help lower death rates by facilitating prompt treatment before the illness worsens. Raising awareness and making screening more accessible are motivating more people to take part, which will ultimately result in earlier diagnoses and higher long-term survival rates for patients with lung cancer.
4. Growth in Personalized and Targeted Therapies
Treatment for lung cancer is becoming much more effective due to the development of tailored and targeted medicines. Healthcare professionals can find particular mutations or biomarkers in a patient's tumour by employing molecular profiling and genetic testing. With the use of this data, customised treatment programs that take into account the unique cancer features of each patient can be created. Personalised methods enhance surgical planning, cut down on pointless procedures, and raise the possibility of successful results. In addition to surgery, targeted therapy can be utilised to reduce tumour size before surgery or stop recurrence after surgery. This increase is indicative of a move towards precision medicine, which provides patients with more individualised, less invasive, and effective care across the course of their lung cancer journey.
5. Enhanced Imaging and Navigation Technologies
Improved accuracy and surgical results are revolutionising lung cancer procedures because of improved imaging and navigation technologies. Surgeons can accurately find tumours and important structures inside the lungs because of sophisticated equipment, including real-time navigation systems, intraoperative CT scans, and 3D imaging. These technologies lower the chance of harming healthy tissue by aiding in the planning and direction of minimally invasive surgeries. Better evaluation of tumour margins and lymph node involvement is made possible by enhanced visualisation, and this is essential for total tumour removal. Incorporating these imaging methods into surgical procedures promotes safer, more efficient procedures, expedites patient recuperation, and enhances treatment outcomes overall.
Empower your strategic planning:
Stay informed with the latest industry insights and market trends to identify new opportunities and drive growth in the lung cancer surgery market. To explore more in-depth trends, insights, and forecasts, please refer to our detailed report.
Top 23 Companies Leading the Lung Cancer Surgery Market
- Johnson & Johnson
- Ethicon
- KARL STORZ SE & CO. KG
- Medrobotics Corporation
- Accuray Incorporated
- Novartis AG
- Boston Scientific Corporation
- ANGIODYNAMICS
- BECTON, DICKINSON AND COMPANY
- Stryker Corporation
- Olympus Corporation
- Teleflex Incorporated
- Siemens Healthineers AG
- GE Healthcare
- Intuitive Surgical Inc.
- Medtronic Plc.
- Scanlan International Inc.
- Richard Wolf GmbH
- Trokamed GmbH
- Varian Medical Systems
- Ackermann Instrumente GmbH
- Phoenix Surgical Holdings Limited –
- KLS Martin Group
- Others
1. Johnson & Johnson
Headquarters: New Jersey, USA
A world leader in healthcare, Johnson & Johnson is well-known for its wide range of consumer health goods, medications, and medical devices. Advanced surgical staplers and haemostatic technologies that improve minimally invasive treatments are the focus of its subsidiary Ethicon in the lung cancer surgery sector. Johnson & Johnson places a high priority on clinical outcome improvement, surgeon training, and innovation. The business is dedicated to developing surgical solutions to raise the standard of patient care everywhere.
2. Ethicon
Headquarters: Ohio, USA
Ethicon is a Johnson & Johnson business that specialises in surgical technology and devices. It is especially well-known for its minimally invasive surgical solutions, haemostatic products, and sophisticated surgical staplers. The company's primary goals are to improve patient outcomes and surgical precision in a variety of medical specialties, including lung cancer surgery. Ethicon makes significant R&D investments to offer cutting-edge instruments and thorough surgeon education programs. It is a major player in the market for surgical equipment because of its dedication to quality and innovation.
3. KARL STORZ SE & CO. KG
Headquarters: Tuttlingen, Germany
An industry leader in the production of surgical tools and endoscopic equipment, KARL STORZ SE & CO. KG is well-known for producing top-notch visualisation systems that are utilised in minimally invasive surgeries, such as those for lung cancer. By providing modular systems that improve surgical accuracy and patient safety, the company places a strong emphasis on optical technology innovation. KARL STORZ provides thorough training and technical assistance to medical professionals in order to enhance clinical results. renowned for its dedication to technological innovation and excellence.
4. Medrobotics Corporation
Headquarters: Massachusetts, USA
The goal of Medrobotics Corporation's cutting-edge robotic devices is to enhance minimally invasive surgery. Its flagship device, the Flex Robotic System, is especially useful for challenging procedures like lung cancer surgery because it gives doctors better dexterity and vision in difficult-to-reach anatomical locations. The organisation prioritises safety, innovation, and the use of precise technologies to improve patient outcomes. Medrobotics provides continuous technical support and training to surgeons.
5. Accuray Incorporated
Headquarters: Wisconsin, USA
The medical equipment business Accuracy Incorporated specialises in radiation therapy systems for the treatment of cancer, notably lung cancer. Its core technologies, like the TomoTherapy and CyberKnife systems, provide accurate, non-invasive tumour targeting with the least amount of harm to nearby healthy tissue. Accuray prioritises advancements in adaptive and image-guided radiation therapy to improve patient outcomes and treatment precision. Through continuing education and assistance, the organisation works collaboratively with healthcare providers to improve cancer care.
Are you ready to discover more about the lung cancer surgery market?
The report provides an in-depth analysis of the leading companies operating in the global Lung Cancer Surgery market. It includes a comparative assessment based on their product portfolios, business overviews, geographical footprint, strategic initiatives, market segment share, and SWOT analysis. Each company is profiled using a standardized format that includes:
Company Profiles
- Johnson & Johnson
- Business Overview
- Company Snapshot
- Products Overview
- Company Market Share Analysis
- Company Coverage Portfolio
- Financial Analysis
- Recent Developments
- Merger and Acquisitions
- SWOT Analysis
- Ethicon
- KARL STORZ SE & CO. KG
- Medrobotics Corporation
- Accuray Incorporated
- Infor
- Novartis AG
- Boston Scientific Corporation
- ANGIODYNAMICS
- Others
Conclusion
The lung cancer surgery market is driven by the rising incidence of lung cancer worldwide, which raises demand for both traditional and less invasive surgical techniques. Improved survival rates and market expansion are being facilitated by improved product advertising and early detection initiatives. For early-stage treatment, surgery is still crucial, frequently in conjunction with radiation or chemotherapy. Additionally, in order to increase their market presence and quicken the growth of the business, major competitors are implementing inorganic growth techniques, including acquisitions.
About the Spherical Insights & Consulting
Spherical Insights & Consulting is a market research and consulting firm which provides actionable market research study, quantitative forecasting and trends analysis provides forward-looking insight especially designed for decision makers and aids ROI.
Which is catering to different industry such as financial sectors, industrial sectors, government organizations, universities, non-profits and corporations. The company's mission is to work with businesses to achieve business objectives and maintain strategic improvements.
CONTACT US:
For More Information on Your Target Market, Please Contact Us Below:
Phone: +1 303 800 4326 (the U.S.)
Phone: +91 90289 24100 (APAC)
Email: inquiry@sphericalinsights.com, sales@sphericalinsights.com
Contact Us: https://www.sphericalinsights.com/contact-us
Need help to buy this report?